Home » GPhA Targets FDA’s ANDA Stability Guidance, Saying it Raises New Questions
GPhA Targets FDA’s ANDA Stability Guidance, Saying it Raises New Questions
GPhA is asking for more clarification on the FDA’s recent guidance, Abbreviated New Drug Applications; Stability Testing of Drug Substances and Products: Questions and Answers.
Regulatory Focus
Regulatory Focus
Upcoming Events
-
07May
-
14May
-
30May